TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for <i>De Novo</i> Modeling and Simulation From Experimental Data

The Target-Mediated Drug Disposition (TMDD) model is an important framework in pharmacokinetics (PK) and pharmacodynamics (PD), providing insights into drug interactions with soluble and membrane-bound targets, particularly for monoclonal antibodies. This paper reviews TMDD modeling specifically focused on monoclonal antibodies targeting soluble ligands, synthesizing existing research and highlighting current advancements. By doing so, we aim to enhance understanding of the application and potential of TMDD modeling in predicting drug behavior and optimizing therapeutic outcomes for soluble targets.

Publication Details

Journal
Clinical Pharmacology & Therapeutics
Published
2026-03-24
DOI
https://doi.org/10.1002/cpt.70255
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data

Clinical Pharmacology & Therapeutics
Monoclonal and Polyclonal Antibodies Research
article

TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data

article en

Abstract

The Target-Mediated Drug Disposition (TMDD) model is an important framework in pharmacokinetics (PK) and pharmacodynamics (PD), providing insights into drug interactions with soluble and membrane-bound targets, particularly for monoclonal antibodies. This paper reviews TMDD modeling specifically focused on monoclonal antibodies targeting soluble ligands, synthesizing existing research and highlighting current advancements. By doing so, we aim to enhance understanding of the application and potential of TMDD modeling in predicting drug behavior and optimizing therapeutic outcomes for soluble targets.

Clinical Pharmacology & Therapeutics
Good health and well-being
Openalex Percentile: Top 11%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for <i>De Novo</i> Modeling and Simulation From Experimental Data · Clinical Pharmacology & Therapeutics (2026) | TGRS Research Map | TGRS